Cargando…

Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study

BACKGROUND AND OBJECTIVE: Radiation pneumonitis (RP) could be a lethal complication of lung cancer treatment. No reliable predictors of RP severity have been recognized. This prospective pilot study was performed to identify early predictors of high grade lung toxicity and to evaluate clinical, biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Aso, Samantha, Navarro-Martin, Arturo, Castillo, Richard, Padrones, Susana, Castillo, Edward, Montes, Ana, Martínez, José Ignacio, Cubero, Noelia, López, Rosa, Rodríguez, Laura, Palmero, Ramon, Manresa, Federico, Guerrero, Thomas, Molina, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590478/
https://www.ncbi.nlm.nih.gov/pubmed/33109238
http://dx.doi.org/10.1186/s13014-020-01694-1
_version_ 1783600810616160256
author Aso, Samantha
Navarro-Martin, Arturo
Castillo, Richard
Padrones, Susana
Castillo, Edward
Montes, Ana
Martínez, José Ignacio
Cubero, Noelia
López, Rosa
Rodríguez, Laura
Palmero, Ramon
Manresa, Federico
Guerrero, Thomas
Molina, María
author_facet Aso, Samantha
Navarro-Martin, Arturo
Castillo, Richard
Padrones, Susana
Castillo, Edward
Montes, Ana
Martínez, José Ignacio
Cubero, Noelia
López, Rosa
Rodríguez, Laura
Palmero, Ramon
Manresa, Federico
Guerrero, Thomas
Molina, María
author_sort Aso, Samantha
collection PubMed
description BACKGROUND AND OBJECTIVE: Radiation pneumonitis (RP) could be a lethal complication of lung cancer treatment. No reliable predictors of RP severity have been recognized. This prospective pilot study was performed to identify early predictors of high grade lung toxicity and to evaluate clinical, biological or dosimetric features associated with different grades of toxicity. METHOD: Sixteen patients with non-small cell lung cancer with indication of concurrent chemoradiotherapy using 60 Gy/2 Gy/fraction starting at cycle one of platinum based chemotherapy were included. Bronchoalveolar lavage (BAL), pulmonary function testing (PFT), and (18)F-2-fluoro-2-deoxy-D-glucose positron-emission tomography was performed before radiotherapy (RT), after three weeks of treatment, and two months post-RT. For analysis, patients were grouped by grade (low [G1-G2] vs. high [G3-G5]). The two groups were compared to identify predictors of RP. Protein expression BAL and lung tissue metabolism was evaluated in two patients (RP-G1 vs. RP-G3). Categorical variables such as comorbidities, stages and locations were summarized as percentages. Radiation doses, pulmonary function values and time to RP were summarized by medians with ranges or as means with standard deviation. Longitudinal analysis PFT was performed by a T-test. RESULTS: All 16 patients developed RP, as follows: G1 (5 pts; 31.3%); G2 (5 pts; 31.3%); G3 (5 pts; 31.3%); and G5 (1 pts; 6.1%). Patients with high grade RP presented significant decrease (p = 0.02) in diffusing lung capacity for carbon monoxide (DLCO) after three weeks of RT. No correlation between dosimetric values and RP grades was observed. BAL analysis of the selected patients showed that CXCL-1, CD154, IL-1ra, IL-23, MIF, PAI-1 and IFN-γ were overexpressed in the lungs of the RP-G3 patient, even before treatment. The pre-RT SUVmax value in the RP-G3 patient was non-significantly higher than in the patient with RP-G1. CONCLUSIONS: RT induces some degree of RP. Our data suggest that decrease in DLCO% is the most sensitive parameter for the early detection of RP. Moreover, we detect biological differences between the two grades of pneumonitis, highlighting the potential value of some cytokines as a prognostic marker for developing high grade lung toxicity. Further multicenter studies with larger sample size are essential to validate these findings.
format Online
Article
Text
id pubmed-7590478
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75904782020-10-27 Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study Aso, Samantha Navarro-Martin, Arturo Castillo, Richard Padrones, Susana Castillo, Edward Montes, Ana Martínez, José Ignacio Cubero, Noelia López, Rosa Rodríguez, Laura Palmero, Ramon Manresa, Federico Guerrero, Thomas Molina, María Radiat Oncol Research BACKGROUND AND OBJECTIVE: Radiation pneumonitis (RP) could be a lethal complication of lung cancer treatment. No reliable predictors of RP severity have been recognized. This prospective pilot study was performed to identify early predictors of high grade lung toxicity and to evaluate clinical, biological or dosimetric features associated with different grades of toxicity. METHOD: Sixteen patients with non-small cell lung cancer with indication of concurrent chemoradiotherapy using 60 Gy/2 Gy/fraction starting at cycle one of platinum based chemotherapy were included. Bronchoalveolar lavage (BAL), pulmonary function testing (PFT), and (18)F-2-fluoro-2-deoxy-D-glucose positron-emission tomography was performed before radiotherapy (RT), after three weeks of treatment, and two months post-RT. For analysis, patients were grouped by grade (low [G1-G2] vs. high [G3-G5]). The two groups were compared to identify predictors of RP. Protein expression BAL and lung tissue metabolism was evaluated in two patients (RP-G1 vs. RP-G3). Categorical variables such as comorbidities, stages and locations were summarized as percentages. Radiation doses, pulmonary function values and time to RP were summarized by medians with ranges or as means with standard deviation. Longitudinal analysis PFT was performed by a T-test. RESULTS: All 16 patients developed RP, as follows: G1 (5 pts; 31.3%); G2 (5 pts; 31.3%); G3 (5 pts; 31.3%); and G5 (1 pts; 6.1%). Patients with high grade RP presented significant decrease (p = 0.02) in diffusing lung capacity for carbon monoxide (DLCO) after three weeks of RT. No correlation between dosimetric values and RP grades was observed. BAL analysis of the selected patients showed that CXCL-1, CD154, IL-1ra, IL-23, MIF, PAI-1 and IFN-γ were overexpressed in the lungs of the RP-G3 patient, even before treatment. The pre-RT SUVmax value in the RP-G3 patient was non-significantly higher than in the patient with RP-G1. CONCLUSIONS: RT induces some degree of RP. Our data suggest that decrease in DLCO% is the most sensitive parameter for the early detection of RP. Moreover, we detect biological differences between the two grades of pneumonitis, highlighting the potential value of some cytokines as a prognostic marker for developing high grade lung toxicity. Further multicenter studies with larger sample size are essential to validate these findings. BioMed Central 2020-10-27 /pmc/articles/PMC7590478/ /pubmed/33109238 http://dx.doi.org/10.1186/s13014-020-01694-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Aso, Samantha
Navarro-Martin, Arturo
Castillo, Richard
Padrones, Susana
Castillo, Edward
Montes, Ana
Martínez, José Ignacio
Cubero, Noelia
López, Rosa
Rodríguez, Laura
Palmero, Ramon
Manresa, Federico
Guerrero, Thomas
Molina, María
Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
title Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
title_full Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
title_fullStr Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
title_full_unstemmed Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
title_short Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
title_sort severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590478/
https://www.ncbi.nlm.nih.gov/pubmed/33109238
http://dx.doi.org/10.1186/s13014-020-01694-1
work_keys_str_mv AT asosamantha severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT navarromartinarturo severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT castillorichard severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT padronessusana severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT castilloedward severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT montesana severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT martinezjoseignacio severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT cuberonoelia severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT lopezrosa severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT rodriguezlaura severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT palmeroramon severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT manresafederico severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT guerrerothomas severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy
AT molinamaria severityofradiationpneumonitisfromclinicaldosimetricandbiologicalfeaturesapilotstudy